Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.

@article{Long2012RiskOM,
  title={Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.},
  author={Millie D. Long and Christopher F. Martin and Clare A Pipkin and Hans H. Herfarth and Robert S. Sandler and Michael D. Kappelman},
  journal={Gastroenterology},
  year={2012},
  volume={143 2},
  pages={390-399.e1}
}
BACKGROUND & AIMS Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to determine the risk of melanoma and nonmelanoma skin cancer (NMSC) in patients with IBD and how medications affect these risks. METHODS We performed retrospective cohort and nested case-control studies using administrative data from the LifeLink Health Plan Claims Database from 1997 to 2009. The cohort comprised 108,579 patients with IBD, and each was matched to 4 individuals… CONTINUE READING
Highly Influential
This paper has highly influenced 14 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 10 times over the past 90 days. VIEW TWEETS
117 Citations
40 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 117 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

[ Long term treatment of psoriasis with TNF - alpha antagonists . Occurrence of malignant melanoma

  • L Kowalzick, L Eickenscheidt, M Komar
  • Hautarzt
  • 2011

Similar Papers

Loading similar papers…